MPISX
Price
$7.00
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
170.93M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

MPISX vs RMEBX

Header iconMPISX vs RMEBX Comparison
Open Charts MPISX vs RMEBXBanner chart's image
BNY Mellon Income Stock M
Price$7.00
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets170.93M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
MPISX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MPISX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPISX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. MPISX (171M). MPISX pays higher dividends than RMEBX: MPISX (1.52) vs RMEBX (1.16). MPISX was incepted earlier than RMEBX: MPISX (25 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than MPISX (0.90). MPISX is a more actively managed with annual turnover of: 92.12 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than MPISX: RMEBX (250) vs MPISX (10000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. MPISX (-7.44). RMEBX return over 5 years is better than : 49.85 vs. MPISX (-0.02).
MPISXRMEBXMPISX / RMEBX
Total Expense Ratio0.901.0784%
Annual Report Gross Expense Ratio0.901.0784%
Fund Existence25 years11 years-
Gain YTD3.7445.34970%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets171M105B0%
Annual Yield % from dividends1.521.16131%
Returns for 1 year-7.448.30-90%
Returns for 3 years-22.3117.96-124%
Returns for 5 years-0.0249.85-0%
Returns for 10 years-13.7168.21-20%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA